KARS1 and bladder transitional cell carcinoma: Higher GARS1 mRNA levels correspond to significantly worse survival in five different cancer types (BLCA, KIRC, LGG, LIHC, and LUAD) compared to only one for KARS1 (HNSC) (Figure 4).